Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, hosted a conference call at 10:00 (Eastern Time) on November 13, 2018 to discuss the financial results for the quarter.
Bill Leonard, President and CEO of Greenbrook TMS Inc. highlights the Company’s expansion plans, market potential and its history of building TMS centers across the U.S
Greenbrook TMS’ executives and Board of Directors were pleased to open the market at the Toronto Stock Exchange on Friday October 12th, 2018 following the Company’s listing on the TSX exchange under the symbol GTMS.
Greenbrook TMS is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder (MDD) in the United States. Greenbrook TMS currently operates through 47 company-operated treatment centers with plans to add new treatment centers in 2019 and beyond.